Drugs Affecting Blood Formation and Coagulability

Author(s):  
Frederick “Fritz” T. Fraunfelder ◽  
Frederick “Rick” W. Fraunfelder
Keyword(s):  
1950 ◽  
Vol 1 (1) ◽  
pp. 355-376
Author(s):  
Gurth Carpenter
Keyword(s):  

Science ◽  
2014 ◽  
Vol 345 (6199) ◽  
pp. 943-949 ◽  
Author(s):  
D. Lara-Astiaso ◽  
A. Weiner ◽  
E. Lorenzo-Vivas ◽  
I. Zaretsky ◽  
D. A. Jaitin ◽  
...  

Development ◽  
2002 ◽  
Vol 129 (8) ◽  
pp. 1881-1892 ◽  
Author(s):  
Annette Damert ◽  
Lucile Miquerol ◽  
Marina Gertsenstein ◽  
Werner Risau ◽  
Andras Nagy

Vascular endothelial growth factor A (VEGFA) plays a pivotal role in the first steps of endothelial and haematopoietic development in the yolk sac, as well as in the establishment of the cardiovascular system of the embryo. At the onset of gastrulation, VEGFA is primarily expressed in the yolk sac visceral endoderm and in the yolk sac mesothelium. We report the generation and analysis of a Vegf hypomorphic allele, Vegflo. Animals heterozygous for the targeted mutation are viable. Homozygous embryos, however, die at 9.0 dpc because of severe abnormalities in the yolk sac vasculature and deficiencies in the development of the dorsal aortae. We find that providing ‘Vegf wild-type’ visceral endoderm to the hypomorphic embryos restores normal blood and endothelial differentiation in the yolk sac, but does not rescue the phenotype in the embryo proper. In the opposite situation, however, when Vegf hypomorphic visceral endoderm is provided to a wild-type embryo, the ‘Vegf wild-type’ yolk sac mesoderm is not sufficient to support proper vessel formation and haematopoietic differentiation in this extra-embryonic membrane. These findings demonstrate that VEGFA expression in the visceral endoderm is absolutely required for the normal expansion and organisation of both the endothelial and haematopoietic lineages in the early sites of vessel and blood formation. However, normal VEGFA expression in the yolk sac mesoderm alone is not sufficient for supporting the proper development of the early vascular and haematopoietic system.


1954 ◽  
Vol 11 (2) ◽  
pp. 114-128 ◽  
Author(s):  
Sam J. Piliero ◽  
Albert S. Gordon

2018 ◽  
Vol 19 (9) ◽  
pp. 2567 ◽  
Author(s):  
Joanna Konieczny ◽  
Lorena Arranz

Blood formation, or haematopoiesis, originates from haematopoietic stem cells (HSCs), whose functions and maintenance are regulated in both cell- and cell non-autonomous ways. The surroundings of HSCs in the bone marrow create a specific niche or microenvironment where HSCs nest that allows them to retain their unique characteristics and respond rapidly to external stimuli. Ageing is accompanied by reduced regenerative capacity of the organism affecting all systems, due to the progressive decline of stem cell functions. This includes blood and HSCs, which contributes to age-related haematological disorders, anaemia, and immunosenescence, among others. Furthermore, chronological ageing is characterised by myeloid and platelet HSC skewing, inflammageing, and expanded clonal haematopoiesis, which may be the result of the accumulation of preleukaemic lesions in HSCs. Intriguingly, haematological malignancies such as acute myeloid leukaemia have a high incidence among elderly patients, yet not all individuals with clonal haematopoiesis develop leukaemias. Here, we discuss recent work on these aspects, their potential underlying molecular mechanisms, and the first cues linking age-related changes in the HSC niche to poor HSC maintenance. Future work is needed for a better understanding of haematopoiesis during ageing. This field may open new avenues for HSC rejuvenation and therapeutic strategies in the elderly.


Sign in / Sign up

Export Citation Format

Share Document